Clin2
NCT07428473Possibly a fitRecruiting

Study of STX-1150 for high cholesterol

Elevated LDL-C and High Cholesterol

Part of Heart & circulation, Hormones & metabolism clinical trials.

This early-phase trial tests a new medication called STX-1150 for people with high LDL cholesterol. It aims to see if the drug is safe and how well it works to lower cholesterol.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
64 people
Ages
18 years to 70 years
Study type
Interventional

Who can take part

  • You have high LDL cholesterol (bad cholesterol), even if you're already taking medication for it.
  • You are willing to follow the study procedures and give written permission (consent) to participate.
  • You have NOT had a heart attack, stroke, or similar event in the last 6 months.
  • You do NOT have any other serious or uncontrolled medical condition that could interfere with the study.
  • You do NOT have a genetic condition called familial hypercholesterolemia.
  • You do NOT have active or past liver disease, and you have not taken certain cholesterol-lowering drugs (like PCSK9 inhibitors) recently.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06568471Recruiting· Phase 3
Study of HST101 for high cholesterol in Chinese patients

This study tests a new injectable medication called HST101 for lowering cholesterol in people who are already taking cholesterol pills but still have high levels. It may help if you have heart disease or are at high risk.

Beijing, Beijing Municipality
NCT07441317Not yet recruiting· Phase 3
Testing a new drug for stubborn high cholesterol

This trial tests a new medication (QLC7401) for people with high cholesterol that is not well controlled by their current treatment. It aims to see if the drug can help lower LDL-C (bad cholesterol) levels and reduce the risk of heart problems.

NCT07491172Recruiting· Phase 1
Trial of CTX310 for stubborn high cholesterol and fats

This trial tests a new medicine, CTX310, for people with persistently high levels of fats (triglycerides) and cholesterol that have not improved with standard treatments. It aims to see if the drug is safe and tolerable.

Hialeah, Florida
NCT06750341Not yet recruiting· Phase 2
Study of QLC7401 for high cholesterol

This trial tests an experimental drug, QLC7401, for people with high LDL cholesterol that hasn't lowered enough with current treatments. It aims to see if the drug can help reduce cholesterol levels in patients who are already on stable cholesterol medication.

NCT07777003Not yet recruiting· Phase 1
Study of a new drug for mild high cholesterol

This trial tests a new drug called HS-10582 in healthy people and those with slightly high LDL cholesterol (a type of cholesterol). The goal is to see if it is safe and how well your body handles it.

NCT07444086Not yet recruiting· Phase 3
A study of a new medicine for high cholesterol

This trial tests if a new drug, QLC7401, can lower cholesterol in people with high cholesterol who are not on other cholesterol medicines. It may be an option if you have low or medium risk of heart disease and no history of heart problems.

Hear when a new Elevated LDL-C and High Cholesterol trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.